Biopharma Firm Seeks DEA Okay to Import Research Controlled Drugs
Published Date: 9/11/2025
Notice
Summary
Biopharmaceutical Research Company wants to get official permission to bring in certain controlled substances for research. This affects the company and anyone tracking drug imports, with no immediate cost changes but a key step in their business process. If approved, they can legally import these substances to help with important medical research.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in